English | Español

Community
+ Community
Caitlin Nordahl | Apr 24, 2017

NIH study tracks gene, antiviral response to Ebola virus
+ Regulatory
Marian Johns | Apr 23, 2017

FDA issues complete response letter for Merck's diabetes drug labeling
Ruth de Jauregui | Apr 22, 2017

Novartis teaming with Allergan in Phase IIb trial of non-alcoholic steatohepatitis treatment therapy
Caitlin Nordahl | Apr 22, 2017

The Medicines Company to highlight its antimicrobial products at conference in Austria
Caitlin Nordahl | Apr 22, 2017

Reports look at gender and ethnic differences in Medicare Advantage care
Ruth de Jauregui | Apr 22, 2017

Hot flashes in younger women may be a factor in heart disease
Ruth de Jauregui | Apr 22, 2017

Genetic component found in childhood absence epilepsy medication response
+ Regulatory
Caitlin Nordahl | Apr 22, 2017

New RA research shows value of biologic treatments greater than initial assessments

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes